Literature DB >> 8821064

Biochemical lesions of the nigrostriatal system by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline) and derivatives.

C Grote1, H W Clement, W Wesemann, G Bringmann, D Feineis, P Riederer, K H Sontag.   

Abstract

In vivo voltammetry with carbon fibre electrodes was used to study the effects of highly halogenated tetrahydro-beta-carbolines on the striatal dopamine (DA) metabolism of the rat. As representatives of chloral-derived heterocycles, "TaClo" (1-trichloro-1,2,3,4-tetrahydro-beta-carboline) and its N-methylated derivative. "N-methyl-TaClo", were investigated. After intranigral injection of 10 micrograms TaClo, the DA activity in the ipsilateral striatum was reduced compared with the intact side. Application of N-methyl-TaClo (10 micrograms) resulted in a nearly total reduction of the DOPAC signal. Furthermore, also "TaBro" (1-tribromomethyl-1,2,3,4-tetrahydro-beta-carboline), the bromal-derived analogue of TaClo, was tested. The impairment of the DA metabolism in rats achieved with 10 micrograms TaBro was found to be between that observed after application of TaClo and N-methyl-TaClo, respectively. The results demonstrate the toxic potential of chloral- and bromal-derived beta-carbolines towards dopaminergic neurons.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8821064

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  8 in total

Review 1.  The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease.

Authors:  K A Jellinger
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

Review 2.  Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

Authors:  M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Trichloroethylene and Parkinson's Disease: Risk Assessment.

Authors:  Mei Liu; Eun-Joo Shin; Duy-Khanh Dang; Chun-Hui Jin; Phil Ho Lee; Ji Hoon Jeong; Seok-Joo Park; Yong-Sun Kim; Bin Xing; Tao Xin; Guoying Bing; Hyoung-Chun Kim
Journal:  Mol Neurobiol       Date:  2017-12-22       Impact factor: 5.590

4.  Effect of 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) on human serotonergic cells.

Authors:  G Bringmann; R Brückner; R Mössner; D Feineis; A Heils; K P Lesch
Journal:  Neurochem Res       Date:  2000-06       Impact factor: 3.996

5.  Cytotoxicity of chloral-derived beta-carbolines is not specific towards neuronal nor dopaminergic cells.

Authors:  A Storch; Y-I Hwang; G Bringmann; D Feineis; S Ott; R Brückner; J Schwarz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-01       Impact factor: 3.575

6.  Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats.

Authors:  Mei Liu; Dong-Young Choi; Randy L Hunter; Jignesh D Pandya; Wayne A Cass; Patrick G Sullivan; Hyoung-Chun Kim; Don M Gash; Guoying Bing
Journal:  J Neurochem       Date:  2009-11-17       Impact factor: 5.372

7.  Mitochondrial dysfunction in Parkinson's disease.

Authors:  P C Keane; M Kurzawa; P G Blain; C M Morris
Journal:  Parkinsons Dis       Date:  2011-03-15

8.  Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice.

Authors:  P C Keane; P S Hanson; L Patterson; P G Blain; P Hepplewhite; A A Khundakar; S J Judge; P J Kahle; F E N LeBeau; C M Morris
Journal:  Neurosci Lett       Date:  2019-08-15       Impact factor: 3.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.